DNP-019
/ Samsung, Kumho HT
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 20, 2020
Samsung Biologics inks development partnership with Dinona for potential COVID-19 treatment
(PRNewswire)
- "Samsung Biologics (207940.KS) has entered into a partnership agreement with biotech Dinona...to non-clinical and clinical material manufacturing. Under this agreement, Samsung and Dinona will collaborate for fast-track development of DNP-019, a potential COVID-19 antibody therapy."
Licensing / partnership • Infectious Disease • Novel Coronavirus Disease
1 to 1
Of
1
Go to page
1